Laura Damme - Dec 14, 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Dec 14, 2022
Transactions value $
-$245,110
Form type
4
Date filed
12/16/2022, 03:30 PM
Previous filing
Feb 24, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $229K +5.95K $38.46 5.95K Dec 14, 2022 Direct
transaction TMDX Common Stock Sale -$371K -5.95K -100% $62.43 0 Dec 14, 2022 Direct F1
transaction TMDX Common Stock Options Exercise $9.62K +250 $38.46 250 Dec 15, 2022 Direct
transaction TMDX Common Stock Sale -$15K -250 -100% $60.02 0 Dec 15, 2022 Direct F2
transaction TMDX Common Stock Options Exercise $182K +4.74K $38.46 4.74K Dec 15, 2022 Direct
transaction TMDX Common Stock Sale -$279K -4.74K -100% $58.96 0 Dec 15, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5.95K -23.79% $0.00 19.1K Dec 14, 2022 Common Stock 5.95K $38.46 Direct F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -250 -1.31% $0.00 18.8K Dec 15, 2022 Common Stock 250 $38.46 Direct F4
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -4.74K -25.21% $0.00 14.1K Dec 15, 2022 Common Stock 4.74K $38.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.